Your browser doesn't support javascript.
loading
A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea.
Chen, Yufan; Watson, Tina R; Criss, Steven D; Eckel, Andrew; Palazzo, Lauren; Sheehan, Deirdre F; Kong, Chung Yin.
Affiliation
  • Chen Y; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Watson TR; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Criss SD; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Eckel A; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Palazzo L; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Sheehan DF; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Kong CY; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
PLoS One ; 14(7): e0220610, 2019.
Article in En | MEDLINE | ID: mdl-31361789
More than 50% of the world's lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model-Asia (LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U.S. Centers for Medicare & Medicaid Services (CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore's low smoking prevalence and South Korea's aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Computer Simulation / Early Detection of Cancer / Health Policy / Lung Neoplasms / Models, Theoretical Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Computer Simulation / Early Detection of Cancer / Health Policy / Lung Neoplasms / Models, Theoretical Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States